We are live on
!
Find out more
GA
Geller Advisors Portfolio holdings
AUM
$1.52B
1-Year Est. Return
20.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.48%
1 Year Est. Return
+20.7%
3 Year Est. Return
+20.44%
5 Year Est. Return
+77.4%
10 Year Est. Return
+246.39%
AUM
$424M
AUM Growth
+$26.2M
(+6.6%)
Cap. Flow
+$7.68M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
86.96%
Holding
131
New
12
Increased
94
Reduced
12
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$10.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$7.38M |
| 3 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$1.94M |
| 4 |
Apple
AAPL
|
+$864K |
| 5 |
Microsoft
MSFT
|
+$849K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$17.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.51M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$400K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$382K |
| 5 |
Procter & Gamble
PG
|
+$358K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.22% |
| 2 | Technology | 4.21% |
| 3 | Financials | 2.43% |
| 4 | Communication Services | 1.95% |
| 5 | Consumer Discretionary | 1.6% |
Similar funds
ZB
IFLIT
MIIM
NIMI
EWM
CFGS
RDIA
WP
Geller Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Geller Advisors held 131 positions worth $424M, up 6.6% from $398M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Geller Advisors's Q1 2021 filing shows 12 new, 94 increased, 12 reduced and 10 closed positions. Its largest new stake was NovoCure: 68,405 shares worth $9.04M. The largest sale was iShares Russell 3000 ETF, an estimated $17.5M.
By sector, the portfolio is most concentrated in Healthcare at 4.2% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Geller Advisors's largest Q1 2021 buy was NovoCure: 68,405 shares worth $9.04M.
- Geller Advisors added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $7.38M increase.
- Geller Advisors's biggest Q1 2021 reduction was iShares Russell 3000 ETF, cutting an estimated $17.5M.
- Geller Advisors fully exited Bristol-Myers Squibb in Q1 2021, selling an estimated $382K.
- Geller Advisors's ten largest holdings make up 87% of its $424M portfolio in Q1 2021.
- Geller Advisors opened 12 new positions and closed 10 in Q1 2021.
- Geller Advisors's portfolio value rose 6.6% quarter-over-quarter to $424M.
Based on Geller Advisors's 13F filing for Q1 2021, filed 10 May 2021.